Health Magazine: Why do I suddenly have allergies?
UC allergist says genetics and environment play a role in allergies
A journalist from Heath spoke with Dr. Jonathan Bernstein, professor in UC Department of Internal Medicine, about the supposedly sudden appearance of allergies in some individuals despite decades of not being bothered with a condition that affects more than 50 million Americans, according to the Asthma and Allergy Foundation.
Technically speaking, you aren’t experiencing a new allergy, Bernstein told Health. It's more likely that you've had the allergy for a while, but you're only now experiencing symptoms. So, what gives? There's a process that can occur in the body called sensitization, Dr. Bernstein explains where your body produces an antibody after having contact with an allergen, but you don’t experience symptoms. Eventually, those antibodies are activated, albeit it could take some time.
Related Stories
Recent advances may speed time to endometriosis diagnosis
March 16, 2026
The average time to clinical diagnosis of endometriosis is nine years. Definitive diagnosis of the disease is difficult, and until recently, has relied on laparoscopic surgery. Now, as Medscape recently reported, novel clinical recommendations, advanced diagnostic tools and research into inflammation and immune responses, are bringing promise that women with endometriosis will find relief sooner and without surgery, according to experts, including Katie Burns, PhD, University of Cincinnati College of Medicine associate professor.
Local media highlight completion of Blood Cancer Healing Center fourth and fifth floors
March 16, 2026
Local media including WLWT and the Cincinnati Business Courier highlighted the opening of research laboratories and the UC Osher Wellness Suite and Learning Kitchen at the University of Cincinnati Cancer Center’s Blood Cancer Healing Center.
Trial results support weekly buprenorphine treatment of opioid use disorder during pregnancy
March 16, 2026
Supported by the National Institutes of Health (NIH), researchers led by the University of Cincinnati's John Winhusen published clinical trial results in JAMA Internal Medicine that found administering weekly injectable extended-release buprenorphine for treatment of opioid use disorder during pregnancy led to higher rates of abstinence from illicit opioids than buprenorphine given daily under the tongue, one of the standard methods of treatment.